the effectiveness and safety of dexmedetomidine plus oxycodone hydrochloride for awake anesthesia during painless colonoscopy.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017283

Enrollment

Unknown

Registered

2018-07-20

Start date

2018-09-22

Completion date

Unknown

Last updated

2018-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colonoscopy

Interventions

group A:dexmedetomidine plus oxycodone

group B:propofol+sufentanil

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) class I or II, BMI 30 to 35, 30 to 60 years of age, and elective colonoscopy

Exclusion criteria

Exclusion criteria: severe hypertension, coronary heart disease, bradycardia, neurological or mental illness, liver and kidney dysfunction, alcoholism

Design outcomes

Primary

Measure	Time frame
breathe;pulse oxygen saturation;Blood Pressure;	—

Countries

China

Contacts

Public ContactZhang Zhen

Suqian People's Hospital of Nanjing Drum Tower Hospital Group

3586440862@qq.com+86 18012186031

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026